Report of unusual clinical appearance in bacteraemia with non-haemolytic M-type 58 Streptococcus pyogenes

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 17-21

  Weightman, Nigel C ^a   Barnham, Michael R D ^b  

^a FRIARAGE HOSPITAL   (United Kingdom)

^b HARROGATE DISTRICT HOSPITAL   (United Kingdom)

Author keywords

M type 58; Non haemolytic variants; Streptococcus pyogenes

Indexed keywords

AGAR; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; FLUCLOXACILLIN; METRONIDAZOLE; PENICILLIN G; STREPTOLYSIN S;

AEROBIC CELL CULTURE; AGED; ARTICLE; BACTEREMIA; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; CASE REPORT; CLINICAL FEATURE; DERMATITIS; DIAGNOSTIC ERROR; FEMALE; HEMOLYSIS; HUMAN; LABORATORY DIAGNOSIS; LEUKEMIA; MALE; MEDICAL RECORD; RETROPHARYNGEAL ABSCESS; SEPTICEMIA; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; UNITED KINGDOM;

AGED; BACTEREMIA; HUMANS; MALE; STREPTOCOCCUS PYOGENES;

EID: 3442883094     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Colebrook L, Elliott SD, Maxted WR, Morley CW, Mortell M. Infection by non-haemolytic group A streptococci. Lancet 1942; ii: 30-1.
2. Rammelkamp CH, Dingle JH. Pathogenic streptococci. Annu Rev Microbiol 1948; 2: 279-304.
3. James L, McFarland RB. An epidemic of pharyngitis due to a nonhemolytic group A streptococcus at Lowry Air Force Base. New Engl J Med 1971; 284: 750-2.
4. Chapman SS. Unusual group A streptococci: colonial appearance and hemolysis. In: Wannamaker LW, Matsen JM, editors. Streptococci and streptococcal diseases: recognition, understanding and management. New York: Academic Press; 1972 p. 211-33.
5. Skjold SA, Maxted WR, Wannamaker LW. Transduction of the genetic determinant for streptolysin S in group A streptococci. Infect Immun 1982; 38: 183-8.
6. Taylor MB, Barkham T. Fatal case of pneumonia caused by a nonhaemolytic strain of Streptococcus pyogenes. J Clin Microbiol 2002; 40: 2311-2.
7. Dierksen KP, Tagg JR. Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis. J Med Microbiol 2000; 49: 811-6.
8. Colman G. Streptococcus and Lactobacillus. In: Parker MT, Duerden BI, editors. Topley and Wilson's principles of bacteriology, virology and immunity, vol.2, 8th ed. London Edward Arnold; 1990 p. 119-59.
9. Barnham M, Weightman N. Streptococcus pyogenes bacteraemia: a 16-year case sequence in North Yorkshire. Clin Microbiol Infect 1997; 3 (Suppl 2): 131.
10. Barnham M. A study of streptococcal skin sepsis in meat and poultry handlers. MD Thesis. London, UK: University of London; 1989.
11. Barnham M. Bacteraemia in streptococcal infections of the throat. J Inject 1983; 7: 203-9.
12. Cleary PP, Pritchard KH, McShan WM, Ferretti JJ. Group A streptococcal genetics and virulence. In: Stevens DL, Kaplan EL, editors. Streptococcal infections: clinical aspects, microbiology and molecular pathogenesis. New York: Oxford University Press; 2000 p. 37-56.
13. Betschel SD, Borgia SM, Barg NL, Low DE, DeAzavedo JC. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun 1998: 66: 1671-9.
14. Nizet V, Beall B, Bast DJ, Datta V, Kilburn L, Low DE, et al. Genetic locus for streptolysin S production by group A streptococcus. Infect Immun 2000; 68: 4245-54.
15. Ginsburg I. Is streptolysin S of group A streptococci a virulence factor? APMIS 1999; 107: 1051-9.
16. Humar D, Datta V, Bast DJ, Beall B, De Azavedo JCS, Nizet V, et al. Streptolysin S and necrotising infections produced by group G streptococcus. Lancet 2002; 359: 124-9.
17. Top FH, Wannamaker LW. The serum opacity reaction of Streptococcus pyogenes: frequency of production of streptococcal lipoproteinase by strains of different serological types and the relationship to M protein production. J Hyg Camb 1968; 66: 49-58.
18. Pinney AM, Widdowson JP, Maxted WR. Inhibition of beta-haemolysis by opacity factor in group A streptococci. J Hyg Camb 1977; 78: 355-62.
19. Martin DR. Laboratory evaluation of streptococci. In: Stevens DL, Kaplan EL, editors. Streptococcal infections: clinical aspects, microbiology and molecular pathogenesis. New York: Oxford University Press; 2000 p. 266-79.
20. Berheimer AW. Hemolysins of streptococci: characterization and effects on biological membranes. In: Wannamaker LW, Matsen JM, editors. Streptococci and streptococcal diseases: recognition, understanding and management. New York: Academic Press; 1972 p. 19-31.
21. Potter EV, Poon-King T, Svartman M, Burt EG, Sharrett AR, Bray JP, et al. Unusual streptococcal strains in Trinidad and their relation to nephritis and rheumatic fever. In: Haverkorn MJ, editor. Streptococcal disease and the community. Amsterdam : Excerpta Medica; 1974 p. 285-300.
22. Gaworzewska E, Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect 1988; 100: 257-69.
23. Colman G, Tanna A, Efstratiou A, Gaworzewska ET. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993; 39: 165-78.
24. Bessen DE, Izzo MW, Fiorentino TR, Caringal RM, Hollingshead SK, Beall B. Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J Infect Dis 1999; 179: 627-36.
25. Prakash K, Dutta S. Antibodies to streptococccal opacity factor in a selected Indian population. J Med Microbiol 1991; 34: 119-24.
26. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, et al. emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis 1999; 5: 247-53.
27. Beall B, Facklam R, HoenesT, Schwartz B. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol 1997; 35: 1231-5.
28. Barnham M. Nonsteroidal antiinflammatory drugs: concurrent or causative drugs in serious infection? Clin Infect Dis 1997; 25: 1272-3.